Role of fish oil in human health and possible mechanism to reduce the inflammation

Inflammopharmacology

Volumn 23, Issue 2-3, 2015, Pages 79-89

  Ellulu, Mohammed S ^a   Khaza’ai, Huzwah ^a   Abed, Yehia ^b   Rahmat, Asmah ^a   Ismail, Patimah ^a   Ranneh, Yazan ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b AL QUDS UNIVERSITY   (Palestine)

Author keywords

C reactive protein; Cancer; Cardiovascular diseases; Inflammation; Interleukin 6; Mechanism; Metabolic syndrome; Obesity; Omega 3 fatty acids; Polyunsaturated fatty acids

Indexed keywords

C REACTIVE PROTEIN; FISH OIL; INTERLEUKIN 6; OMEGA 3 FATTY ACID; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT; BIOLOGICAL MARKER;

ANTIINFLAMMATORY ACTIVITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DEPRESSION; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG MECHANISM; HUMAN; INFLAMMATION; META ANALYSIS (TOPIC); METABOLIC SYNDROME X; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PHASE 1 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW (TOPIC); ANIMAL; DIET THERAPY; METABOLISM;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BIOMARKERS; FATTY ACIDS, OMEGA-3; FISH OILS; HUMANS; INFLAMMATION;

EID: 84929843768     PISSN: 09254692     EISSN: 15685608     Source Type: Journal    
DOI: 10.1007/s10787-015-0228-1     Document Type: Review

References (85)

1. Adkins Y, Kelley D (2010) Mechanisms underlying the cardioprotective effects of Omega-3 polyunsaturated fatty acids: review current topic. J Nutr Biochem 21:781–792
2. Angulo P (2007) Obesity and nonalcoholic fatty liver disease. Nutr Rev 65:S57–S63
3. Benatti P, Peluso G, Nicolai R, Calvani M (2004) Polyunsaturated fatty acids: biochemical, nutritional and epigenetic properties. J Am Coll Nutr 23:281–302
4. Bhatnagar D, Durrington PN (2003) Omega-3 fatty acids: their role in the prevention and treatment of atherosclerosis related risk factors and complications. Int J Clin Pract 57:305–314
5. Blaschke F, Takata Y, Caglayan E, Collins A, Tontonoz P, Hsueh WA, Tangirala RK (2006) A nuclear receptor corepressor-dependent pathway mediates suppression of cytokine-induced C-reactive protein gene expression by liver X receptor. Circ Res 99:e88–e99
6. Boura-Halfon S, Zick Y (2009) Phosphorylation of IRS proteins, insulin action, and insulin resistance. Am J Physiol 296(4):E581–E591
7. Bouwens M, van de Rest O, Dellschaft N, Bromhaar MG, de Groot L, Geleijnse J, Muller M, Afman L (2009) Fish-oil supplementation induces antiinflammatory gene expression profiles in human blood mononuclear cells. Am J Clin Nutr 90:415–424
8. Bowden RG, Wilson RL, Deike E et al (2011) Fish oil supplementation lowers C-reactive protein levels independent of triglyceride reduction in patients with end-stage renal disease. Nutr Clin Pract 24:508–512
9. Brenna JT, Salem N, Sinclair AJ, Cunnane SC (2009) Alpha-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot Essent Fatty Acids 80:85–91
10. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC et al (2004) Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40:1387–1395
11. Caughey GE, Mantzioris E, Gibson RA, Cleland L, James M (1996) The effect on human tumor necrosis factor α and interleukin 1β production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 63:116–122
12. Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, Hui JM, Fung C et al (2002) NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 35:373–379
13. Chowdhury R, Stevens S, Gorman D, Pan A, Warnakula S, Chowdhury S, et al. (2012). Association between fish consumption, long chain Omega 3 fatty acids, and risk of cerebrovascular disease: systematic review and meta-analysis. Br Med J 345. doi: 10.1136/bmj.e6698
14. Cinti S, Mitchell G, Barbatelli G et al (2005) Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 46(11):2347–2355
15. De Caterina R, Libby P (1996) Control of endothelial leukocyte adhesion molecules by fatty acids. Lipids 31:S57–S63
16. Delgado-Lista J, Perez-Martinez P, Lopez-Miranda J, Perez-Jimenez F (2012) Long chain Omega-3 fatty acids and cardiovascular disease: a systematic review. Br J Nutr 107:S201–S213
17. Din JN, Newby DE, Flapan AD (2004) Omega-3 fatty acids and cardiovascular disease- fishing for a natural treatment. BMJ 328:30–35
18. Duda MK, O’Shea KM, Tintinu A, Xu W, Khairallah RJ, Barrows BR, Chess DJ, Azimzadeh AM, Harris WS, Sharov VG, Sabbah HN, Stanley WC (2009) Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload-induced cardiac dysfunction. Cardiovasc Res 81:319–327
19. Emanuela F, Grazia M, Marco DR, Paola LM, Giorgio F, Marco B (2012) Inflammation as a Link between Obesity and Metabolic Syndrome: review Article. J Nutri and Metab. doi:10.1155/2012/476380
20. Engler MM, Engler MB, Malloy MJ (2005) Effect of docosahexaenoic acid on lipoprotein subclasses in hyperlipidemic children (the EARLY study). Am J Cardiol 95:869–871
21. Evans M, Mahaney PE, Zhang S, Gantan E, Borges-Marcucci L, Lai KD, Wang S, Harnish DC (2007) A synthetic farnesoid X receptor agonist protects against diet-induced dyslipidemia. Circulation 116(16):106
22. FAO/WHO (2010) Fats and fatty acids in human nutrition Report of an expert consultation. 91 (66), Rome
23. Forman BM, Goode E, Chen J, Oro AE, Bradley DJ, Perlmann T, Noonan DJ, Burka LT, McMorris T, Lamph WW, Evans RM, Weinberger C (1995) Identification of a nuclear receptor that is activated by farnesol metabolites. Cell 81:687–693
24. Freund-Levi Y, Hjorth E, Lindberg C et al (2009) Effects of Omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in Alzheimer’s disease: the OmegaD study. Dement Geriatr Cogn Disord 27:481–490
25. Geelen A, Brouwer IA, Zock PL, Katan MB (2004) Antiarrhythmic effects of n-3 fatty acids: evidence from human studies. Curr Opin Lipidol 15:25–30
26. Gerber M (2012) Omega-3 fatty acids and cancers: a systematic update review of epidemiological studies. Br J Nutr 107:S228–S239
27. Halberg N, Wernstedt-Asterholm I, Scherer PE (2008) The adipocyte as an endocrine cell. Endocrinol Metab Clin North Am 37(3):753–768
28. Hooper L, Thompson RL, Harrison RA, Summerbell C, Ness A et al (2006) Risks and benefits of Omega-3 fats for mortality, cardiovascular disease, and cancer: systematic review. BMJ. doi:10.1136/bmj.38755.366331.2F
29. Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance”. Science 259(5091):87–91
30. Itariu B, Zeyda Z, Hochbrugger E, Neuhofer A et al (2012) Long-chain n23 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial. Am J Clin Nutr 96:1137–1149
31. Jenkins D, Josse A (2008) Fish oil and Omega-3 fatty acids: fact sheet. Can Med Assoc J 178(2):150. doi:10.1503/cmaj.071754
32. Johnson IT (2002) Anticarcinogenic effects of dietrelated apoptosis in the colorectal mucosa. Food Chem Toxicol 40:1171–1178
33. Jump DB (2002) The biochemistry of n-3 polyunsaturated fatty acids. J Biol Chem 277:8755–8758
34. Karastergiou K, Mohamed-Ali V (2010) The autocrine and paracrine roles of adipokines. Mol Cell Endocrinol 318(1–2):69–78
35. Khalfoun B, Thibault F, Watier H, Bardos P, Lebranchu Y (1997) Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human endothelial cell production of interleukin-6. Adv Exp Med Biol 400:589–597
36. Kiecolt-Glaser J, Belury M, Andridge R, Malarkey W, Glaser R (2011) Omega-3 supplementation lowers inflammation and anxiety in medical students: a randomized controlled trial. Brain Behav Immun 25(8):1725–1734
37. Kiecolt-Glaser J, Belury M, Andridge R, Malarkey W, Hwang B, Glaser R (2012) Omega-3 supplementation lowers inflammation in healthy middle-aged and older adults: a randomized controlled trial. Brain Behav Immun 26(6):988–995
38. Lee KW, Lip GYH (2003) The role of Omega-3 fatty acids in secondary prevention of cardiovascular disease. Q J Med. 96:465–480
39. Li L, Wilson A, Kuruba R, Zhang Q, Gao X, He F, Zhang LM, Pitt BR, Xie W, Li S (2008) FXR-mediated regulation of eNOS expression in vascular endothelial cells. Cardiovasc Res 77:169–177
40. Lichtenstein AH, Jones PJH (2001) Lipids: absorption and transport. present knowledge in nutrition. ILSI press, Washington, DC, pp 92–103
41. Lin PY, Su KP (2007) A Meta-Analytic Review of Double-Blind, Placebo-Controlled Trials of Antidepressant Efficacy of Omega-3 Fatty Acids. J Clin Psychiatry 68:1056–1061
42. MacLean C, Newberry S, Mojica W, Khanna P, Issa A, Suttorp M, Lim YW, Traina S, Hilton L, Garland R, Morton S (2006) Effects of Omega-3 fatty acids on cancer risk: a systematic review. JAMA 295:403–415
43. Makhoul Z, Kristal AR, Gulati R, Luick B, Bersamin A, O’Brien D, Hopkins SE, Stephensen CB, Stanhope KL, Havel PJ, Boyer B (2011) Associations of obesity with triglycerides and C-reactive protein are attenuated in adults with high red blood cell eicosapentaenoic and docosahexaenoic acids. Eur J Clin Nutr 65(7):808–817
44. Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, Hull MV, Lustig KD, Mangelsdorf DJ, Shan B (1999) Identification of a nuclear receptor for bile acids. Science 284:1362–1365
45. Marik P, Varon J (2009) Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review. Clin Cardiol 32(7):365–372
46. McNamara RK, Jandacek R, Rider T, Tso P, Cole-Strauss A, Lipton JW (2010) Omega-3 fatty acid deficiency increases constitutive pro-inflammatory cytokine production in rats: relationship with central serotonin turnover. Prostaglandins Leukot Essent Fatty Acids 83(4–6):185–191
47. Medzhitov R (2008) Origin and physiological roles of inflammation. Nature 454(7203):428–435
48. Micallef MA, Munro IA, Garg ML (2009) An inverse relationship between plasma n-3 fatty acids and C-reactive protein in healthy individuals. Eur J Clin Nutr 63:1154–1156
49. Murray CJ, Lopez AD (1997) Alternative projections of mortality and disability by cause 1990–2020: global burden of disease study. Lancet 349:1498–1504
50. Nodari S, Triggiani M, Campia U, Manerba A, Milesi G, Cesana BM, Gheorghiade M, Dei Cas L (2011) Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in patients with dilated cardiomyopathy. J Am Coll Cardiol 57:870–879
51. O’Keefe JH Jr, Abuissa H, Sastre A, Steinhaus DM, Harris WS (2006) Effects of Omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions. Am J Cardiol 97(8):1127–1130
52. Parker HM, Johnson N, Burdon C, Cohn J, O’Connor H, George J (2012) Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta- analysis. J Hepatol 56:944–951
53. Peoples GE, McLennan PL, Howe PR and Groeller H (2008) Fish oil reduces heart rate and oxygen consumption during exercise. J Cardiovasc Pharmacol 52:540–547
54. Pot GK, Brouwer IA, Enneman A et al (2009) No effect of fish oil supplementation on serum inflammatory markers and their interrelationships: a randomized controlled trial in healthy, middle-aged individuals. Eur J Clin Nutr 63:1353–1359
55. Rader D (2007) Liver X receptor and farnesoid X receptor as therapeutic targets. Am J Cardiol 100:n15–n19
56. Rangel-Huerta OD, Aguilera CM, Mesa MD, Gil A (2012) Omega-3 long-chain polyunsaturated fatty acids supplementation on inflammatory biomakers: a systematic review of randomised clinical trials. Br J Nutr 107:S159–S170
57. Renier G, Skamene E, de Sanctis J, Radzioch D (1993) Dietary n-3 polyunsaturated fatty acids prevent the development of atherosclerotic lesions in mice: modulation of macrophage secretory activities. Arterioscler Thomb 13:1515–1524
58. Rizos E, Ntzani E, Bika E, Kostapanos M, Elisaf M (2012) Association between Omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA 308(10):1024–1033
59. Romano M (2008) Inflammation resolution: does the bone marrow have a say? Am J Hematol 83:435–436
60. Sanyal AJ, Chalasani N, Kowdley KV, McCullough A, Diehl AM, Bass NM et al (2010) Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med 362:1675–1685
61. Seki H, Tani Y, Arita M (2009) Omega-3 PUFA derived anti-inflammatory lipid mediator resolvin E1. Prostaglandins Other Lipid Mediat 89:126–130
62. Serhan CN, Chiang N, Van Dyke TE (2008) Resolving inflammation: dual anti-inflammatory and pro- resolution lipid mediators. Nat Rev Immunol 8:349–361
63. Simopoulos A (1991) Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 54:438–463
64. Simopoulos A (2002) The importance of the ratio of Omega-6/Omega-3 essential fatty acids. Biomed Pharmacother 56:365–379
65. Skulas-Ray A, Kris-Etherton P, Harris W, Vanden Heuvel J, Wagner P, West S (2011) Dose-response effects of Omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia. Am J Clin Nutr 93:243–252
66. Stark AH, Crawford M, Reifen R (2008) Update on alpha-linolenic acid. Nutr Rev 66(6):326–332
67. Stenlof K, Wernstedt I, Fjallman T, Wallenius V, Wal-lenius K, Jansson JO (2003) Interleukin-6 levels in the central nervous system are negatively correlated with fat mass in overweight/obese subjects. J Clin Endocrinol Metab 88(9):4379–4383
68. Stern MP, Williams K, Gonzalez-Villalpando C, Hunt KJ, Haffner SM (2004) Does the metabolic-syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care 27(11):2676–2681
69. Stryer L (1995) Fatty acids metabolism, in Biochemistry. Ed WH Freeman and Company. New York pp 603–627
70. Takezaki T, Inoue M, Kataoka H et al (2003) Diet and lung cancer risk from a 14-year population-based prospective study in Japan: with special reference to fish consumption. Nutr Cancer 45:160–167
71. Tanskanen A, Hibbeln JR, Hintikka J et al (2001) Fish consumption, depression, and suicidality in a general population. Arch Gen Psychiatry 58:512–513
72. Tao H, Szeszel-Fedorowicz W, Amir-Ahmady B, Gibson MA, Stabile LP, Salati LM (2002) Inhibition of the splicing of glucose-6-phosphate dehydrogenase precursor mRNA by polyunsaturated fatty acids. J Biol Chem 277:31270–31278
73. Targher G, Arcaro G (2007) Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis 191:235–240
74. Teran-Garcia M, Rufo C, Nakamura MT, Osborne TF, Clarke SD (2002) NF-Y involvement in the polyunsaturated fat inhibition of fatty acid synthase gene transcription. Biochem Biophys Res Commun 290:1295–1299
75. Thies F, Garry JM, Yaqoob P, Rerkasm K, Williams J, Shearman CP et al (2003) Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomized controlled trial. Lancet 361:477–485
76. Trayhurn P, Wood I (2004) Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92(3):347–355
77. Trebble T, Arden NK, Stroud MA, Wootton SA, Burdge GC, Miles EA, Ballinger AB, Thompson RL, Calder P (2003) Inhibition of tumour necrosis factor-α and interleukin-6 production by mononuclear cells following dietary fish-oil supplementation in healthy men and response to antioxidant co-supplementation. Br J Nutr 90:405–412
78. Tulk HMF, Robinson LE (2009) Modifying the n-6/n-3 polyunsaturated fatty acid ratio of a high-saturated fat challenge does not acutely attenuate postprandial changes in inflammatory markers in men with metabolic syndrome. Metabolism 58:1709–1716
79. Wang X, Li W, Li N et al (2008) w-3 Fatty Acids-Supplemented Parenteral Nutrition Decreases hyperinflammatory response and attenuates systemic disease sequelae in severe acute pancreatitis: a Randomized and controlled study. Nutr Clin Pract Nutr Clin Pract 32:236–241
80. Wu J, Micha R, Imamura F, Pan A, Biggs M, Ajaz O, Djousse L, Hu F, Mozaffarian D (2012) Omega-3 fatty acids and incident type 2 diabetes: a systematic review and meta-analysis. Br J Nutr 107:S214–S227
81. Yaqoob P, Calder PC (1995) Effects of dietary lipid manipulation upon inflammatory mediator production by murine macrophages. Cell Immunol 163:120–128
82. Yunianingtias D, Volker D (2006) Nutritional aspects of non-alcoholic steatohepatitis treatment. Nutr Diet 63:79–90
83. ®) on plasma lipids and inflammatory markers in patients awaiting carotid endarterectomy. Mar Drugs 11:3569–3581. doi:10.3390/md11093569
84. Zhang S, Liu Q, Wang J, Harnish DC (2009) Suppression of interleukin-6-induced Creactive protein expression by FXR agonists. Biochem Biophys Res Commun 379:476–479
85. Zhao YT, Shao L, Teng LL et al (2009) Effects of n-3 polyunsaturated fatty acid therapy on plasma inflammatory markers and N-terminal pro-brain natriuretic peptide in elderly patients with chronic heart failure. J Int Med Res 37:1831–1841